INVEST IN THE FUTURE OF PAIN RELIEF
Pain is universal. It disrupts work, time with family, and quality of life. Through innovations, we can make a difference.
VIRPAX Pharmaceuticals is collaborating with the best minds of the pharmaceutical industry. Working alongside these leaders, we can improve pain management and target pain at its source.
Partner with us as we develop the next generation of pharmaceutical products that can minimize pain and improve people’s lives.
BECOME A PARTNER
484.880.4588 info@virpaxpharma.com
Virpax Pharmaceuticals Announces Appointment of Christopher M. Chipman, Chief Financial Officer
Virpax Pharmaceuticals Inc. (“Virpax”), a company specializing in developing pharmaceutical products that incorporate the use of novel drug delivery systems for pain management, today announced the appointment of Christopher M. Chipman, CPA, Chief Financial Officer. “As Chairman of the Audit Committee, it is with great pleasure that I welcome Chris [...]
Virpax Pharmaceuticals Strengthens Board of Directors with Appointment of Gary S. Jacob, Ph.D. to its Board
Virpax Pharmaceuticals Inc. (“Virpax”), a company specializing in developing pharmaceutical products that incorporate the use of novel drug delivery systems for pain management, today announced the appointment of Gary S. Jacob, Ph.D. to its Board of Directors.“We are pleased to welcome Dr. Jacob as a new independent director to [...]
Virpax Pharmaceuticals Announces Successful Completion of Pre-IND Meeting with FDA on Epoladerm for the Management of Osteoarthritis of the Knee
505(b)(2) Regulatory Pathway and Proposed Study Design Is Acceptable Virpax to Finalize IND and Prepare for Phase I Human Study Virpax Pharmaceuticals Inc. (“Virpax”), a company specializing in developing pharmaceutical products for pain management by using new drug delivery systems, today announced that it has successfully completed a [...]